NH TherAguix is a clinical stage company, specializing in nanomedicine for cancer radiotherapy. The Company produces and develops its drug candidate AGuIX, for the treatment of solid cancers, with the potential to increase the survival rate of cancer patients, as well as their quality of life when it is combined with radiotherapy.